Aldea Pharmaceuticals' Series B Round

Aldea Pharmaceuticals raised a round of funding on August 25, 2014.

Aldea Pharmaceuticals is focused on developing small molecule modulators of the aldehyde dehydrogenase enzyme superfamily. The scientific approach was discovered by Stanford University researchers and…

Articles about Aldea Pharmaceuticals' Series B Round: